Long-term effectiveness of secondary prevention in patients with acute coronary syndrome

被引:0
作者
Ryzhikova, I. B. [2 ]
Pogosova, N. V. [1 ]
Koltunov, I. E. [1 ]
Pozdnyakov, Yu. M. [2 ]
Vygodin, V. A. [1 ]
机构
[1] State Res Ctr Prevent Med, Moscow, Russia
[2] Moscow Reg Cardiol Ctr, Zhukovskii, Moscow Region, Russia
来源
CARDIOVASCULAR THERAPY AND PREVENTION | 2009年 / 8卷 / 07期
关键词
Cardiovascular disease; acute coronary syndrome; risk factors; secondary prevention; treatment; MYOCARDIAL-INFARCTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To investigate the levels and prevalence of main risk factors (RFs) in patients with acute coronary syndrome (ACS), to evaluate the long-term effectiveness of secondary prevention and its agreement with Russian and international guidelines (2005-2006). Material and methods. A cross-sectional, retrospective analysis of medical histories was performed for 278 patients, hospitalized at the Moscow Regional Cardiology Centre (Zhukovsky) and State Research Centre for Preventive Medicine (Moscow) with myocardial infarction (MI). A subsequent questionnaire survey and examination of these patients provided the general information and the data on laboratory and instrumental test results, number of hospitalizations, work status dynamics, and current treatment. Results. Both in-hospital and long-term prevalence of RFs was high: for body mass index (BMI) >= 25 kg/m(2) - 34,62%, for systolic blood pressure (SBP) >= 140 mm Hg - 26,28%, for smoking - 18,22%, for clinical symptoms of depression and anxiety - 19,23% and 23,42%, respectively. Heart rate (HR), blood lipids, and fasting blood glucose levels were higher than the respective target levels. Conclusion. The long-term RF prevalence in MI patients was high, with inadequate effectiveness of secondary preventive measures, and insufficient clinical implementation of existing international and local standards of CV prevention and therapy
引用
收藏
页码:59 / 63
页数:5
相关论文
共 20 条
[1]  
[Anonymous], 1997, Eur Heart J, V18, P1569
[2]  
[Anonymous], 2002, RED RISKS PROM HLTH
[3]  
Bata IR, 2000, CAN J CARDIOL, V16, P589
[4]  
Giampaoli S, 2001, Ital Heart J, V2, P349
[5]   Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries -: Principal results from EUROASPIRE II Euro Heart Survey Programme [J].
Kotseva, K ;
Wood, D ;
De Backer, G ;
De Bacquer, D ;
Pyöräla, K ;
Keil, U .
EUROPEAN HEART JOURNAL, 2001, 22 (07) :554-572
[6]  
Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]
[7]   Nonlipid primary and secondary prevention strategies for coronary heart disease [J].
Maron, DJ .
CLINICAL CARDIOLOGY, 1996, 19 (05) :419-423
[8]   Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993 [J].
Marques-Vidal, P ;
Ruidavets, JB ;
Cambou, JP ;
Ferrières, J .
HEART, 2000, 84 (02) :171-175
[9]  
OGANOV RG, 2004, KARDIOVASK TER PROF, V3, P10
[10]  
OGANOV RG, 2002, KARDIOVASK TER PROF, V3, P4